Kinase inhibitors modulate huntingtin cell localization and toxicity - PubMed (original) (raw)

. 2011 May 29;7(7):453-60.

doi: 10.1038/nchembio.582.

Affiliations

• PMID: 21623356
• DOI: 10.1038/nchembio.582

Kinase inhibitors modulate huntingtin cell localization and toxicity

Randy Singh Atwal et al. Nat Chem Biol. 2011.

Abstract

Two serine residues within the first 17 amino acid residues of huntingtin (N17) are crucial for modulation of mutant huntingtin toxicity in cell and mouse genetic models of Huntington's disease. Here we show that the stress-dependent phosphorylation of huntingtin at Ser13 and Ser16 affects N17 conformation and targets full-length huntingtin to chromatin-dependent subregions of the nucleus, the mitotic spindle and cleavage furrow during cell division. Polyglutamine-expanded mutant huntingtin is hypophosphorylated in N17 in both homozygous and heterozygous cell contexts. By high-content screening in live cells, we identified kinase inhibitors that modulated N17 phosphorylation and hence huntingtin subcellular localization. N17 phosphorylation was reduced by casein kinase-2 inhibitors. Paradoxically, IKKβ kinase inhibition increased N17 phosphorylation, affecting huntingtin nuclear and subnuclear localization. These data indicate that huntingtin phosphorylation at Ser13 and Ser16 can be modulated by small-molecule drugs, which may have therapeutic potential in Huntington's disease.

PubMed Disclaimer

Comment in

• Huntington's disease: flipping a switch on huntingtin.
  Greiner ER, Yang XW. Greiner ER, et al. Nat Chem Biol. 2011 Jun 17;7(7):412-4. doi: 10.1038/nchembio.604. Nat Chem Biol. 2011. PMID: 21685885 No abstract available.

Similar articles

• Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization.
  DiGiovanni LF, Mocle AJ, Xia J, Truant R. DiGiovanni LF, et al. Hum Mol Genet. 2016 Sep 15;25(18):3937-3945. doi: 10.1093/hmg/ddw234. Epub 2016 Jul 27. Hum Mol Genet. 2016. PMID: 27466181 Free PMC article.
• Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
  Valencia A, Reeves PB, Sapp E, Li X, Alexander J, Kegel KB, Chase K, Aronin N, DiFiglia M. Valencia A, et al. J Neurosci Res. 2010 Jan;88(1):179-90. doi: 10.1002/jnr.22184. J Neurosci Res. 2010. PMID: 19642201
• Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity.
  Atwal RS, Xia J, Pinchev D, Taylor J, Epand RM, Truant R. Atwal RS, et al. Hum Mol Genet. 2007 Nov 1;16(21):2600-15. doi: 10.1093/hmg/ddm217. Epub 2007 Aug 18. Hum Mol Genet. 2007. PMID: 17704510
• Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin.
  Hackam AS, Hodgson JG, Singaraja R, Zhang T, Gan L, Gutekunst CA, Hersch SM, Hayden MR. Hackam AS, et al. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1047-55. doi: 10.1098/rstb.1999.0457. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434304 Free PMC article. Review.
• Are there multiple pathways in the pathogenesis of Huntington's disease?
  Aronin N, Kim M, Laforet G, DiFiglia M. Aronin N, et al. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):995-1003. doi: 10.1098/rstb.1999.0451. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434298 Free PMC article. Review.

Cited by

• N6-Furfuryladenine is protective in Huntington's disease models by signaling huntingtin phosphorylation.
  Bowie LE, Maiuri T, Alpaugh M, Gabriel M, Arbez N, Galleguillos D, Hung CLK, Patel S, Xia J, Hertz NT, Ross CA, Litchfield DW, Sipione S, Truant R. Bowie LE, et al. Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):E7081-E7090. doi: 10.1073/pnas.1801772115. Epub 2018 Jul 9. Proc Natl Acad Sci U S A. 2018. PMID: 29987005 Free PMC article.
• Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease.
  Gomez-Pastor R, Burchfiel ET, Neef DW, Jaeger AM, Cabiscol E, McKinstry SU, Doss A, Aballay A, Lo DC, Akimov SS, Ross CA, Eroglu C, Thiele DJ. Gomez-Pastor R, et al. Nat Commun. 2017 Feb 13;8:14405. doi: 10.1038/ncomms14405. Nat Commun. 2017. PMID: 28194040 Free PMC article.
• Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties.
  Jayaraman M, Mishra R, Kodali R, Thakur AK, Koharudin LM, Gronenborn AM, Wetzel R. Jayaraman M, et al. Biochemistry. 2012 Apr 3;51(13):2706-16. doi: 10.1021/bi3000929. Epub 2012 Mar 20. Biochemistry. 2012. PMID: 22432740 Free PMC article.
• A flexible polyglutamine hinge opens new doors for understanding huntingtin function.
  Giorgini F. Giorgini F. Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14516-7. doi: 10.1073/pnas.1313668110. Epub 2013 Aug 23. Proc Natl Acad Sci U S A. 2013. PMID: 23975930 Free PMC article. No abstract available.
• Modeling Huntington disease in Drosophila: Insights into axonal transport defects and modifiers of toxicity.
  Krench M, Littleton JT. Krench M, et al. Fly (Austin). 2013 Oct-Dec;7(4):229-36. doi: 10.4161/fly.26279. Epub 2013 Sep 10. Fly (Austin). 2013. PMID: 24022020 Free PMC article.

References

1. 1. J Biol Chem. 2003 Jan 17;278(3):1450-6 - PubMed
2. 1. J Cell Biol. 2009 Dec 28;187(7):1083-99 - PubMed
3. 1. Science. 2004 Apr 2;304(5667):100-4 - PubMed
4. 1. Eur J Biochem. 1998 Aug 15;256(1):201-11 - PubMed
5. 1. Neuron. 2008 Sep 11;59(5):708-21 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information